Medtronic PLC (NYSE:MDT) reported its fiscal fourth quarter 2026 results before the opening bell on Wednesday.

The company posted revenue of $9.81 billion, beating the estimate of $9.62 billion, and EPS of $1.55, in line with the $1.55 estimate, according to Benzinga Pro.

Ahead of quarterly earnings, UBS analyst Priya Sachdeva maintained Medtronic with a Neutral rating while lowering the price target from $104 to $90.

The medical device giant's next quarterly cash dividend of 71 cents per share has an anticipated ex-dividend date in late June 2026 and an estimated payment date in July 2026.

The current trailing 12-month dividend payout for Medtronic stands at $2.84, with a dividend yield of 3.83%.

So, how can investors use its dividend yield to pocket a regular ...